- Home
- TPST vs FOXX Comparison
TPST vs FOXX Comparison
Compare TPST & FOXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TPST | FOXX |
|---|---|---|
| Founded | 2011 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.9M | 16.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TPST | FOXX |
|---|---|---|
| Price | $2.89 | $4.50 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $12.50 | N/A |
| AVG Volume (30 Days) | 242.3K | ★ 2.9M |
| Earning Date | 11-05-2025 | 11-18-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $63,030,415.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 139.29 |
| 52 Week Low | $3.00 | $1.71 |
| 52 Week High | $13.65 | $11.00 |
Technical Indicators
Market Signals| Indicator | TPST | FOXX |
|---|---|---|
| Relative Strength Index (RSI) | 24.62 | 48.95 |
| Support Level | $3.04 | $3.81 |
| Resistance Level | $3.23 | $6.30 |
| Average True Range (ATR) | 0.21 | 1.11 |
| MACD | 0.16 | 0.04 |
| Stochastic Oscillator | 3.69 | 17.44 |
Price Performance
Historical ComparisonAbout TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
About FOXX Foxx Development Holdings Inc.
Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals.